These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 17333104)

  • 41. Cinnamic acid based thiazolidinediones inhibit human P450c17 and 3beta-hydroxysteroid dehydrogenase and improve insulin sensitivity independent of PPARgamma agonist activity.
    Arlt W; Neogi P; Gross C; Miller WL
    J Mol Endocrinol; 2004 Apr; 32(2):425-36. PubMed ID: 15072549
    [TBL] [Abstract][Full Text] [Related]  

  • 42. T33, a novel peroxisome proliferator-activated receptor γ/α agonist, exerts neuroprotective action via its anti-inflammatory activities.
    Wang Y; Yang YS; Tang XC; Zhang HY
    Acta Pharmacol Sin; 2011 Sep; 32(9):1100-8. PubMed ID: 21804572
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Enhancement of insulin signaling through inhibition of tissue lipid accumulation by activation of peroxisome proliferator-activated receptor (PPAR) alpha in obese mice.
    Ide T; Tsunoda M; Mochizuki T; Murakami K
    Med Sci Monit; 2004 Oct; 10(10):BR388-95. PubMed ID: 15448592
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effect of PPARalpha activation of macrophages on the secretion of inflammatory cytokines in cultured adipocytes.
    Murakami K; Bujo H; Unoki H; Saito Y
    Eur J Pharmacol; 2007 Apr; 561(1-3):206-13. PubMed ID: 17320860
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Therapeutic potential of peroxisome proliferators--activated receptor-alpha/gamma dual agonist with alleviation of endoplasmic reticulum stress for the treatment of diabetes.
    Han KL; Choi JS; Lee JY; Song J; Joe MK; Jung MH; Hwang JK
    Diabetes; 2008 Mar; 57(3):737-45. PubMed ID: 18065517
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Indinavir uncovers different contributions of GLUT4 and GLUT1 towards glucose uptake in muscle and fat cells and tissues.
    Rudich A; Konrad D; Török D; Ben-Romano R; Huang C; Niu W; Garg RR; Wijesekara N; Germinario RJ; Bilan PJ; Klip A
    Diabetologia; 2003 May; 46(5):649-58. PubMed ID: 12712244
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Osthole improves glucose and lipid metabolism via modulation of PPARα/γ-mediated target gene expression in liver, adipose tissue, and skeletal muscle in fatty liver rats.
    Qi ZG; Zhao X; Zhong W; Xie ML
    Pharm Biol; 2016; 54(5):882-8. PubMed ID: 26455539
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Isomeric C12-alkamides from the roots of Echinacea purpurea improve basal and insulin-dependent glucose uptake in 3T3-L1 adipocytes.
    Kotowska D; El-Houri RB; Borkowski K; Petersen RK; Fretté XC; Wolber G; Grevsen K; Christensen KB; Christensen LP; Kristiansen K
    Planta Med; 2014 Dec; 80(18):1712-20. PubMed ID: 25371981
    [TBL] [Abstract][Full Text] [Related]  

  • 49. WY-14643 and 9- cis-retinoic acid induce IRS-2/PI 3-kinase signalling pathway and increase glucose transport in human skeletal muscle cells: differential effect in myotubes from healthy subjects and Type 2 diabetic patients.
    Bouzakri K; Roques M; Debard C; Berbe V; Rieusset J; Laville M; Vidal H
    Diabetologia; 2004 Jul; 47(7):1314-23. PubMed ID: 15292987
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Cevoglitazar, a novel peroxisome proliferator-activated receptor-alpha/gamma dual agonist, potently reduces food intake and body weight in obese mice and cynomolgus monkeys.
    Chen H; Dardik B; Qiu L; Ren X; Caplan SL; Burkey B; Boettcher BR; Gromada J
    Endocrinology; 2010 Jul; 151(7):3115-24. PubMed ID: 20484464
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Bixin regulates mRNA expression involved in adipogenesis and enhances insulin sensitivity in 3T3-L1 adipocytes through PPARgamma activation.
    Takahashi N; Goto T; Taimatsu A; Egawa K; Katoh S; Kusudo T; Sakamoto T; Ohyane C; Lee JY; Kim YI; Uemura T; Hirai S; Kawada T
    Biochem Biophys Res Commun; 2009 Dec; 390(4):1372-6. PubMed ID: 19891958
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Design and synthesis of N-[(4-methoxyphenoxy)carbonyl]-N-[[4-[2-(5- methyl-2-phenyl-4-oxazolyl)ethoxy]phenyl]methyl]glycine [Muraglitazar/BMS-298585], a novel peroxisome proliferator-activated receptor alpha/gamma dual agonist with efficacious glucose and lipid-lowering activities.
    Devasthale PV; Chen S; Jeon Y; Qu F; Shao C; Wang W; Zhang H; Cap M; Farrelly D; Golla R; Grover G; Harrity T; Ma Z; Moore L; Ren J; Seethala R; Cheng L; Sleph P; Sun W; Tieman A; Wetterau JR; Doweyko A; Chandrasena G; Chang SY; Humphreys WG; Sasseville VG; Biller SA; Ryono DE; Selan F; Hariharan N; Cheng PT
    J Med Chem; 2005 Mar; 48(6):2248-50. PubMed ID: 15771468
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Evidence for involvement of protein kinase C (PKC)-zeta and noninvolvement of diacylglycerol-sensitive PKCs in insulin-stimulated glucose transport in L6 myotubes.
    Bandyopadhyay G; Standaert ML; Galloway L; Moscat J; Farese RV
    Endocrinology; 1997 Nov; 138(11):4721-31. PubMed ID: 9348199
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Peroxisome proliferator-activated receptor gamma agonist rosiglitazone increases expression of very low density lipoprotein receptor gene in adipocytes.
    Takazawa T; Yamauchi T; Tsuchida A; Takata M; Hada Y; Iwabu M; Okada-Iwabu M; Ueki K; Kadowaki T
    J Biol Chem; 2009 Oct; 284(44):30049-57. PubMed ID: 19706614
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Oleanolic acid induces a dual agonist action on PPARγ/α and GLUT4 translocation: A pentacyclic triterpene for dyslipidemia and type 2 diabetes.
    Loza-Rodríguez H; Estrada-Soto S; Alarcón-Aguilar FJ; Huang F; Aquino-Jarquín G; Fortis-Barrera Á; Giacoman-Martínez A; Almanza-Pérez JC
    Eur J Pharmacol; 2020 Sep; 883():173252. PubMed ID: 32534078
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Rosiglitazone, a PPARγ agonist, ameliorates palmitate-induced insulin resistance and apoptosis in skeletal muscle cells.
    Meshkani R; Sadeghi A; Taheripak G; Zarghooni M; Gerayesh-Nejad S; Bakhtiyari S
    Cell Biochem Funct; 2014 Dec; 32(8):683-91. PubMed ID: 25431031
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Salacia oblonga extract increases glucose transporter 4-mediated glucose uptake in L6 rat myotubes: role of mangiferin.
    Girón MD; Sevillano N; Salto R; Haidour A; Manzano M; Jiménez ML; Rueda R; López-Pedrosa JM
    Clin Nutr; 2009 Oct; 28(5):565-74. PubMed ID: 19477051
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Peroxisome proliferator-activated receptor gamma transactivation-mediated potentiation of glucose uptake by Bai-Hu-Tang.
    Chen CC; Hsiang CY; Chiang AN; Lo HY; Li CI
    J Ethnopharmacol; 2008 Jun; 118(1):46-50. PubMed ID: 18440169
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Irbesartan enhances GLUT4 translocation and glucose transport in skeletal muscle cells.
    Kobayashi T; Akiyama Y; Akiyama N; Katoh H; Yamamoto S; Funatsuki K; Yanagimoto T; Notoya M; Asakura K; Shinosaki T; Hanasaki K
    Eur J Pharmacol; 2010 Dec; 649(1-3):23-8. PubMed ID: 20826135
    [TBL] [Abstract][Full Text] [Related]  

  • 60. PPARγ partial agonist GQ-16 strongly represses a subset of genes in 3T3-L1 adipocytes.
    Milton FA; Cvoro A; Amato AA; Sieglaff DH; Filgueira CS; Arumanayagam AS; de Lima Mdo C; Pitta IR; de Assis Rocha Neves F; Webb P
    Biochem Biophys Res Commun; 2015 Aug; 464(3):718-23. PubMed ID: 26168725
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.